Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin®) for AMD followed by controlateral sympathetic ophthalmia
Authors:
- Dimitrios BrouzasDBDimitrios Brouzas
- Chryssanthi KoutsandreaCKChryssanthi Koutsandrea
- Marilita MoschosMMMarilita Moschos
- Spiros PapadimitriouSPSpiros Papadimitriou
- Ioannis LadasILIoannis Ladas
- Michael ApostolopoulosMAMichael Apostolopoulos
Open Access
- 1 August 2009
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 3, 457-9
Abstract
Peer reviewed article authored by (Dimitrios Brouzas, Chryssanthi Koutsandrea, Marilita Moschos, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 14 references indexed in Scilit:
- Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age‐related macular degenerationClinical & Experimental Ophthalmology, 2008
- Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMDDer Ophthalmologe, 2007
- Retinal Pigment Epithelial Tear After Intravitreal Bevacizumab InjectionAmerican Journal of Ophthalmology, 2006
- Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation StudyInvestigative Ophthalmology & Visual Science, 2006
- Retinal Pigment Epithelial Tear following Intravitreal Injection of Bevacizumab (Avastin)European Journal of Ophthalmology, 2006
- Incidence and management of bevacizumab-related toxicities in colorectal cancerExpert Opinion on Drug Safety, 2006
- Repeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmiaActa Ophthalmologica Scandinavica, 2006
- REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTRetina, 2006
- Intravitreal triamcinolone acetonide in sympathetic ophthalmiaGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2004